Skip to content
Review

Abstract C051: Empowering providers to improve clinical trial access: Feasibility and acceptability of an educational intervention on communication around clinical trials

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · 0 citations

Abstract

As part of a multi-phase behavioral interventional study aimed at improving rates of clinical trial (CT) participation amongst patients (pts) from historically underrepresented groups (HUGS), hematology/oncology attending providers at our institution were offered participation in a 1:1 randomized study evaluating the efficacy of a skill based didactic course (SBDC) focused on CT communication versus usual care in enhancing CT enrollment for HUGS. Co-developed by FCCC investigators and VitalTalk, the course consists of 3 self-directed online modules and 3 collaborative virtual meetings to reflect on skills (6 components total). Core skills of the course focused on introducing the concept of CT early, presenting CTs an alternative to standard options, and identifying and addressing barriers. All providers (N=48) completed a baseline survey on confidence with CT communication and addressing barriers. Those in the SBDC (n=24) arm were offered a second post-course survey. Majority of questions were on a 5-point Likert scale from 1=strongly disagree to 5=strongly agree. Exploratory pre- and post-course survey comparisons were conducted using multiple imputation for missing post-course responses, based on baseline score, years in practice and course completion status. Of the 24 providers on the SBDC arm, 42% completed 5-6 of a total of 6 required components, 21% completed 2-4, and 37% completed 0-1. Both baseline and follow up surveys were completed by 66% (n=16). Between the pre- and post-course surveys, there was improvement in confidence of assessing pt concerns (p=0.006), social barriers (p=0.005), economic barriers (p=0.005), prior pt experiences related to CT (p=0.019), pt understanding of general aspects of CT (p=0.010), and understanding of a specific CT (p=0.029). Providers had increased confidence in addressing pt concerns about CT (p=0.012), addressing social barriers (p=0.005), and in their ability to convey essential information about CT quickly (p=0.001). Providers were also less likely to agree that pts enroll in CT as a last resort (p=0.007) and that doctors only offer CTs as a last resort (p=0.033) on the follow up survey. Of the 14 providers who completed course evaluation, high scores were reported in preparedness and impact on clinical trial communication (Mean=4.41, SD=0.56) and equity-focused communication (Mean=4.04, SD=0.66). Acceptability (AIM), appropriateness (IAM), and feasibility (FIM) scores all exceeded 4.0 on the 5-point scale. Participants reported high levels of perceived course value (Mean=4.36, SD=0.74) and willingness to recommend the course to colleagues (Mean=4.36, SD=0.84). The SBDC was associated with improved confidence in CT communication and was well received amongst providers who did course evaluations. However, <50% of providers in the SBDC arm completed the majority of course components representing an underlying challenge in physician training. Ongoing analysis to assess impact of the SBDC on rates of trial recruitment, particularly HUGS, is underway. Shazia Nakhoda, Madeline Albert, Nicole Harrington, Kelsey Lachow, Zachary Frosch, Linda Fleisher. Empowering providers to improve clinical trial access: Feasibility and acceptability of an educational intervention on communication around clinical trials [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr C051.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.